Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 47

    1.

    Lispro insulin: benefits and limitations.

    Burge MR, Rassam AG, Schade DS.

    Trends Endocrinol Metab. 1998 Oct 1;9(8):337-41.PMID: 18406299 [PubMed - in process]Related articles

    2.

    Efficacy of a pedometer-based physical activity program on parameters of diabetes control in type 2 diabetes mellitus.

    Araiza P, Hewes H, Gashetewa C, Vella CA, Burge MR.

    Metabolism. 2006 Oct;55(10):1382-7.PMID: 16979410 [PubMed - indexed for MEDLINE]Related articles

    3.

    Methimazole-induced hypothyroidism paradoxically decreases homocysteine.

    Colleran KM, Romero LA, Upton DA, Burge MR.

    Metabolism. 2005 Apr;54(4):460-5.PMID: 15798951 [PubMed - indexed for MEDLINE]Related articles

    4.

    Hypoglycaemia in elderly patients with diabetes mellitus: causes and strategies for prevention.

    Chelliah A, Burge MR.

    Drugs Aging. 2004;21(8):511-30. Review.PMID: 15182216 [PubMed - indexed for MEDLINE]Related articles

    5.

    Insulin edema in the twenty-first century: review of the existing literature.

    Chelliah A, Burge MR.

    J Investig Med. 2004 Mar;52(2):104-8. Review.PMID: 15068225 [PubMed - indexed for MEDLINE]Related articles

    6.

    Vitiligo associated with subcutaneous insulin lispro infusion in type 1 diabetes.

    Burge MR, Carey JD.

    Diabetes Care. 2004 Jan;27(1):275-6. No abstract available. PMID: 14694005 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Effects of kelp supplementation on thyroid function in euthyroid subjects.

    Clark CD, Bassett B, Burge MR.

    Endocr Pract. 2003 Sep-Oct;9(5):363-9.PMID: 14583417 [PubMed - indexed for MEDLINE]Related articles

    8.
    9.

    Diabetes mellitus associated with atypical anti-psychotic medications.

    Clark C, Burge MR.

    Diabetes Technol Ther. 2003;5(4):669-83. Review.PMID: 14511422 [PubMed - indexed for MEDLINE]Related articles

    10.

    The role of ethnicity in post-pancreatitis diabetes mellitus.

    Burge MR, Gabaldon-Bates J.

    Diabetes Technol Ther. 2003;5(2):183-8.PMID: 12871608 [PubMed - indexed for MEDLINE]Related articles

    11.

    Putting diabetes to the test: Analyzing glycemic control based on patients' diabetes knowledge.

    Colleran KM, Starr B, Burge MR.

    Diabetes Care. 2003 Jul;26(7):2220-1. No abstract available. PMID: 12832351 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Severe hypoglycemia in adults.

    Carroll MF, Burge MR, Schade DS.

    Rev Endocr Metab Disord. 2003 May;4(2):149-57. Review. No abstract available. PMID: 12766543 [PubMed - indexed for MEDLINE]Related articles

    13.

    Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues.

    Carroll MF, Izard A, Riboni K, Burge MR, Schade DS.

    Diabetes Care. 2002 Dec;25(12):2147-52.PMID: 12453952 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Frequency of the dawn phenomenon in type 2 diabetes: implications for diabetes therapy.

    Carroll MF, Hardy KJ, Burge MR, Schade DS.

    Diabetes Technol Ther. 2002;4(5):595-605.PMID: 12450440 [PubMed - indexed for MEDLINE]Related articles

    15.

    Fasting hyperglycemia predicts the magnitude of postprandial hyperglycemia: implications for diabetes therapy.

    Carroll MF, Izard A, Riboni K, Burge MR, Schade DS.

    Diabetes Care. 2002 Jul;25(7):1247-8. No abstract available. PMID: 12087032 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The mechanism of glucose-induced catecholamine stimulation.

    Rassam AG, Martin P 3rd, Burge MR, Schade DS.

    Metabolism. 2002 Jun;51(6):761-4.PMID: 12037731 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effect of short-term glucose control on glycemic thresholds for epinephrine and hypoglycemic symptoms.

    Burge MR, Sobhy TA, Qualls CR, Schade DS.

    J Clin Endocrinol Metab. 2001 Nov;86(11):5471-8.PMID: 11701724 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Lack of compliance with home blood glucose monitoring predicts hospitalization in diabetes.

    Burge MR.

    Diabetes Care. 2001 Aug;24(8):1502-3. No abstract available. PMID: 11473098 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Potato-lactulose breath hydrogen testing as a function of gastric motility in diabetes mellitus.

    Burge MR, Tuttle MS, Violett JL, Stephenson CL, Schade DS.

    Diabetes Technol Ther. 2000 Summer;2(2):241-8.PMID: 11469266 [PubMed - indexed for MEDLINE]Related articles

    20.

    Thiazolidinediones: a comparative review of approved uses.

    Sood V, Colleran K, Burge MR.

    Diabetes Technol Ther. 2000 Autumn;2(3):429-40. Review.PMID: 11467345 [PubMed - indexed for MEDLINE]Related articles

    21.

    How low can you go? Chronic hypoglycemia versus normal glucose homeostasis.

    Sood V, Costello BA, Burge MR.

    J Investig Med. 2001 Mar;49(2):205-9.PMID: 11288762 [PubMed - indexed for MEDLINE]Related articles

    22.

    Differential effects of fasting and dehydration in the pathogenesis of diabetic ketoacidosis.

    Burge MR, Garcia N, Qualls CR, Schade DS.

    Metabolism. 2001 Feb;50(2):171-7.PMID: 11229425 [PubMed - indexed for MEDLINE]Related articles

    23.

    Sulphonylurea-induced hypoglycaemia in type 2 diabetes mellitus: a review.

    Burge MR, Sood V, Sobhy TA, Rassam AG, Schade DS.

    Diabetes Obes Metab. 1999 Jul;1(4):199-206. Review. No abstract available. PMID: 11228754 [PubMed - indexed for MEDLINE]Related articles

    24.

    What are the barriers to medical care for patients with newly diagnosed diabetes mellitus?

    Burge MR, Lucero S, Rassam AG, Schade DS.

    Diabetes Obes Metab. 2000 Dec;2(6):351-4.PMID: 11225964 [PubMed - indexed for MEDLINE]Related articles

    25.

    Breath hydrogen testing identifies patients with diabetic gastroparesis.

    Burge MR, Tuttle MS, Violett JL, Stephenson CL, Schade DS.

    Diabetes Care. 2000 Jun;23(6):860-1. No abstract available. PMID: 10841012 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Low-dose epinephrine supports plasma glucose in fasted elderly patients with type 2 diabetes.

    Burge MR, Kamin JR, Timm CT, Qualls CR, Schade DS.

    Metabolism. 2000 Feb;49(2):195-202.PMID: 10690944 [PubMed - indexed for MEDLINE]Related articles

    28.

    Low-dose ethanol predisposes elderly fasted patients with type 2 diabetes to sulfonylurea-induced low blood glucose.

    Burge MR, Zeise TM, Sobhy TA, Rassam AG, Schade DS.

    Diabetes Care. 1999 Dec;22(12):2037-43.PMID: 10587839 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Optimal administration of lispro insulin in hyperglycemic type 1 diabetes.

    Rassam AG, Zeise TM, Burge MR, Schade DS.

    Diabetes Care. 1999 Jan;22(1):133-6.PMID: 10333914 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Effect of immediate-release glipizide on hypoglycemic vulnerability in fasted, elderly patients with type 2 diabetes.

    Burge MR, Schmitz-Fiorentino K, Sood V, Schade DS.

    JAMA. 1999 Mar 24-31;281(12):1084-5. No abstract available. PMID: 10188656 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Use of the HemoCue blood glucose analyzer in research studies.

    Rassam AG, Mcleod J, Burge MR, Schade DS.

    Diabetes Care. 1998 Aug;21(8):1369-70. No abstract available. PMID: 9702453 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Prospective evaluation of risk factors for exercise-induced hypogonadism in male runners.

    Skarda ST, Burge MR.

    West J Med. 1998 Jul;169(1):9-12.PMID: 9682624 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Use of a laser skin perforator for determination of capillary blood glucose yields reliable results and high patient acceptability.

    Burge MR, Costello DJ, Peacock SJ, Friedman NM.

    Diabetes Care. 1998 May;21(5):871-3. No abstract available. PMID: 9589261 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Risks of complication following thyroidectomy.

    Burge MR, Zeise TM, Johnsen MW, Conway MJ, Qualls CR.

    J Gen Intern Med. 1998 Jan;13(1):24-31.PMID: 9462491 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    A prospective trial of risk factors for sulfonylurea-induced hypoglycemia in type 2 diabetes mellitus.

    Burge MR, Schmitz-Fiorentino K, Fischette C, Qualls CR, Schade DS.

    JAMA. 1998 Jan 14;279(2):137-43.PMID: 9440664 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Insulins.

    Burge MR, Schade DS.

    Endocrinol Metab Clin North Am. 1997 Sep;26(3):575-98. Review.PMID: 9314016 [PubMed - indexed for MEDLINE]Related articles

    37.

    Small cell carcinoma of the vagina causing Cushing's syndrome by ectopic production and secretion of ACTH: a case report.

    Colleran KM, Burge MR, Crooks LA, Dorin RI.

    Gynecol Oncol. 1997 Jun;65(3):526-9.PMID: 9190988 [PubMed - indexed for MEDLINE]Related articles

    38.

    Idiopathic hypogonadotropic hypogonadism in a male runner is reversed by clomiphene citrate.

    Burge MR, Lanzi RA, Skarda ST, Eaton RP.

    Fertil Steril. 1997 Apr;67(4):783-5.PMID: 9093212 [PubMed - indexed for MEDLINE]Related articles

    39.

    Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus.

    Burge MR, Waters DL, Holcombe JH, Schade DS.

    J Clin Endocrinol Metab. 1997 Mar;82(3):920-4.PMID: 9062507 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Meal composition is a determinant of lispro-induced hypoglycemia in IDDM.

    Burge MR, Castillo KR, Schade DS.

    Diabetes Care. 1997 Feb;20(2):152-5.PMID: 9118763 [PubMed - indexed for MEDLINE]Related articles

    41.

    Diabetes mellitus: 2. Managing type II disease.

    Burge MR, Schade DS.

    Hosp Pract (Minneap). 1996 Dec 15;31(12):51-2, 55-60, 63-6.PMID: 8969679 [PubMed - indexed for MEDLINE]Related articles

    42.

    Diabetes mellitus: 1. Improving control in type I disease.

    Burge MR, Schade DS.

    Hosp Pract (Minneap). 1996 Nov 15;31(11):81-90 passim; discussion 102, 105.PMID: 8941162 [PubMed - indexed for MEDLINE]Related articles

    43.

    Validity of Coat-A-Count insulin RIA kit for quantifying total and free humalog.

    Burge MR, McLeod J, Bowsher RR, Schade DS.

    Clin Chem. 1996 May;42(5):777. No abstract available. PMID: 8653910 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Dietary therapy in type II diabetes mellitus.

    Burge MR, Boyle PJ.

    JAMA. 1995 Mar 15;273(11):898. No abstract available. Erratum in: JAMA 1995 Aug 23-30;274(8):612. PMID: 7869567 [PubMed - indexed for MEDLINE]Related articles

    45.

    Brittle diabetes: etiology and treatment.

    Schade DS, Burge MR.

    Adv Endocrinol Metab. 1995;6:289-319. Review.PMID: 7671100 [PubMed - indexed for MEDLINE]Related articles

    46.

    A treatable cause of recurrent severe hypoglycemia.

    Hardy KJ, Burge MR, Boyle PJ, Scarpello JH.

    Diabetes Care. 1994 Jul;17(7):722-4.PMID: 7924785 [PubMed - indexed for MEDLINE]Related articles

    47.

    Short-term fasting is a mechanism for the development of euglycemic ketoacidosis during periods of insulin deficiency.

    Burge MR, Hardy KJ, Schade DS.

    J Clin Endocrinol Metab. 1993 May;76(5):1192-8.PMID: 8496310 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...

    Recent activity